Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Eye

• Publication date

  2009-01-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/eye.2008.388PMID 19169227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients

  2008cited by this paper
• INTRAVITREAL BEVACIZUMAB (AVASTIN) AS A TREATMENT FOR REFRACTORY MACULAR EDEMA IN PATIENTS WITH UVEITIS: A Pilot Study

  2008cited by this paper
• Inflammatory cystoid macular edema

  2007cited by this paper
• Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.

  2007cited by this paper
• Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin)

  2007cited by this paper
• Intravitreal bevacizumab for treatment of uveitic macular edema.

  2007cited by this paper
• Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous.

  2006cited by this paper
• Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

  2005cited by this paper
• Outcome of intravitreal triamcinolone in uveitis.

  2005cited by this paper
• Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.

  2005cited by this paper
• LONG-TERM EFFECT OF ACETAZOLAMIDE TREATMENT OF PATIENTS WITH UVEITIC CHRONIC CYSTOID MACULAR EDEMA IS LIMITED BY PERSISTING INFLAMMATION

  2005cited by this paper
• Infliximab for chronic cystoid macular edema associated with uveitis.

  2004cited by this paper
• Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.

  2004cited by this paper
• Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.

  2004cited by this paper
• Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment

  2003cited by this paper
• Anti-tumour necrosis factor alpha treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment.

  2003cited by this paper
• Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema.

  2001cited by this paper
• Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1ß, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

  2000cited by this paper
• Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies.

  1998cited by this paper
• Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization.

  1998cited by this paper
• Macular microcirculation in cystoid maculopathy of diabetic patients.

  1995cited by this paper
• The role of cytokines in the pathogenesis of inflammatory eye disease.

  1992cited by this paper
• Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

  1990cited by this paper

• Recent advances in the diagnosis and treatment of refractory ocular inflammatory diseases: focus on uveitic macular edema, acute retinal necrosis, and vitreoretinal lymphoma

  2025cites this paper
• Intravitreal immunotherapy in non-infectious uveitis: an update

  2023cites this paper
• Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis

  2023cites this paper
• Optical Coherence Tomographic Features and Prognostic Values of Macular Edema in Vogt-Koyanagi-Harada Disease

  2022cites this paper
• Systemic prime exacerbates the ocular immune response to heat-killed Mycobacterium tuberculosis

  2022cites this paper
• Long-term Efficacy of TNF-alpha Inhibitors on Persistent Uveitic Macular Edema: A Swiss Multicenter Cohort Study

  2022cites this paper
• Monoclonal antibodies in diabetic retinopathy

  2022cites this paper
• Intraocular therapy in noninfectious uveitis

  2021cites this paper
• Immune-Mediated Retinal Vasculitis in Posterior Uveitis and Experimental Models: The Leukotriene (LT)B4-VEGF Axis

  2021cites this paper
• Licarin A as a Novel Drug for Inflammatory Eye Diseases

  2021cites this paper
• Treatment of Uveitic Macular Edema

  2020cites this paper
• Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective

  2020cites this paper
• Diagnostic and Prognostic Roles of Serum Interleukin-6 Levels in Patients with Uveitis

  2020cites this paper
• Anti-vascular endothelial growth factor in the treatment of macular edema in epidemic retinitis

  2020cites this paper
• Treatment of Non-infectious Uveitis

  2019cites this paper
• The role of interleukins and their inhibitors in the development of autoimmune uveitis.

  2019cites this paper
• Local Drug Delivery for Noninfectious Uveitis

  2019cites this paper
• Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

  2019cites this paper
• Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema

  2019cites this paper
• Update in treatment of uveitic macular edema

  2019cites this paper
• Recent progress in the treatment of uveitic macular edema

  2019cites this paper
• Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUS.

  2018cites this paper
• Cytokines in uveitis

  2018cites this paper
• Anti-interleukin-23 therapy options and studies in patients with uveitis

  2018cites this paper
• Intravitreal bevacizumab versus triamcinolone acetonide for uveitic cystoid macular edema: a metaanalysis

  2017cites this paper
• Inflammatory optic disc neovascularisation managed with oral steroids/immunosuppressants and intravitreal ranibizumab

  2017cites this paper
• Makulaödem bei Uveitis – Steroide oder VEGF-Inhibitoren?

  2017influential citation
• Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review

  2017cites this paper
• A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization

  2017cites this paper
• Novel therapeutic targets in uveitis

  2017cites this paper
• Medical Management of CME Associated with Uveitis

  2017cites this paper
• Intraocular Drug Delivery

  2016cites this paper
• Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment

  2016cites this paper
• Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration

  2016cites this paper
• Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review

  2016cites this paper
• Uveitic Macular Edema: Treatment Update

  2016cites this paper
• Management of pseudophakic cystoid macular edema.

  2015cites this paper
• Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration

  2015cites this paper
• Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases.

  2015cites this paper
• Anti-tumor necrosis factor-α therapy in uveitis.

  2015cites this paper
• Antietumor necrosis factor-a therapy in uveitis

  2015cites this paper
• Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature

  2015cites this paper
• Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration

  2015cites this paper
• OPTICAL COHERENCE TOMOGRAPHY–GUIDED RANIBIZUMAB INJECTION FOR CYSTOID MACULAR EDEMA IN WELL-CONTROLLED UVEITIS: Twelve-Month Outcomes

  2014cites this paper
• Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur intravitrealen Therapie des Makulaödems bei Uveitis

  2014cites this paper
• [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].

  2014cites this paper
• The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

  2014cites this paper
• Utilisation d'un antagoniste du vegf dans le traitement d'un œdème maculaire

  2014cites this paper
• Cystoid Macular Edema

  2014cites this paper
• Pharmacotherapy for uveitis: current management and emerging therapy

  2014cites this paper
• A Dedicated Low-Cost Fluorescence Microfluidic Device Reader for Point-of-Care Ocular Diagnostics

  2013cites this paper
• Local therapies for inflammatory eye disease in translation: past, present and future

  2013cites this paper
• Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges

  2013cites this paper
• Birdshot uveitis: current and emerging treatment options

  2013cites this paper
• Improved diffuse fluorescence flow cytometer prototype for high sensitivity detection of rare circulating cells in vivo

  2013cites this paper
• Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis

  2013cites this paper
• Corticosteroid-sparing agents: new treatment options.

  2012cites this paper
• Changes in the Intraocular Cytokine Levels after Intravitreal Bevacizumab in Uveitic Macular Edema

  2012cites this paper
• Postcataract surgical inflammation

  2012cites this paper
• CAPÍTULO 11 – Tratamiento con anti-TNF-α del edema macular uveítico

  2012cites this paper
• Review and update of intraocular therapy in noninfectious uveitis

  2011cites this paper
• The Intravitreal Use of Corticosteroids - Balancing Benefit and Risk

  2011cites this paper
• Uveitis in celiac disease with an excellent response to gluten-free diet: third case described

  2011cites this paper
• Clinical Review: Update on Treatment of Inflammatory Macular Edema

  2011cites this paper
• EFFICACY AND SAFETY OF INTRAVITREAL BEVACIZUMAB COMPARED WITH INTRAVITREAL AND POSTERIOR SUB-TENON TRIAMCINOLONE ACETONIDE FOR TREATMENT OF UVEITIC CYSTOID MACULAR EDEMA

  2011cites this paper
• INTRAOCULAR AND SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN ACUTE RETINAL NECROSIS AND OCULAR TOXOPLASMOSIS

  2010cites this paper
• Drug Delivery Options for the Treatment of Ocular Inflammation

  2010cites this paper
• The intravitreal use of corticosteroids

  2010cites this paper
• Vascular endothelial growth factor inhibition in uveitis: a systematic review

  2010influential citation
• Recent advances in drug delivery systems for treating ocular complications of systemic diseases

  2009cites this paper